Intuitive's annual report
2020 Focus
"As we enter 2020, we are focused on the following business objectives for the year. First, growth in general surgery, particularly in the United States. Second, deepening our skills and performance in key markets in Europe and Asia, in particular by building strength beyond urology. Third, advancing our product innovation in SP, Ion, advanced instruments, endoscopy, and informatics. Finally, continuing to expand clinical, economic and hospital-by-hospital validation in key procedures and countries.Our business requires the contributions of a diverse and increasingly global workforce. From our founding, we have been the beneficiaries of the work of an outstanding team of highly capable people. At the end of 2019, we employed roughly 7,300 people residing in 27 countries. We are committed to serving our customers, enabling and cultivating our employees, and investing in the communities in which we live and work. This January, we published our first Corporate Sustainability Report, which can be found at https://isrg.gcs-web.com/investors.Many of you have been investors in our company for years, and some of you are recipients of da Vinci surgery. Thank you for your continued support in this journey to improve surgery and acute intervention. I assure you that we are focused on delivering products and services that truly make a difference."
Gary Guthart, Ph.D.Chief Executive Officer
Further analysis was published on Seeking Alpha.
Source: Intuitive
Comments